FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for DILANTIN (extended phenytoin sodium), a new extended-release form from Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure Disorders

Drugs mentioned

• DILANTIN (Phenytoin sodium, extended release)

Snippet

SUPPL AP for DILANTIN (EXTENDED PHENYTOIN SODIUM)